ORM2 and rheumatoid arthritis: While limited by short experimental durations and a lack of ORM2-neutralizing antibodies, the research established ORM2 as a promising biomarker and therapeutic target in RA, with liver-derived ORM2 potentially contributing to RA pathogenesis [111].